Related Experiment Video
Updated: Jun 26, 2026
09:16
Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
Epilepsy after head injury: an overview.
1Department of Neurology, University of California, San Francisco, California 94143, USA. lowenstein@medsch.ucsf.edu
Epilepsia
|February 4, 2009
Summary
Traumatic brain injury (TBI) is a significant cause of acquired epilepsy, with risk increasing with injury severity. Developing biomarkers for antiepileptogenesis therapies is crucial for TBI patients, especially in light of modern warfare head trauma.
Area of Science:
- Neurology
- Neurotrauma
- Epileptology
Background:
- Traumatic brain injury (TBI) is a well-established cause of epilepsy.
- The incidence of epilepsy following TBI correlates directly with injury severity.
- A significant portion of TBI survivors develop epilepsy months or years post-injury, highlighting a critical window for intervention.
Purpose of the Study:
- To emphasize the importance of TBI as a cause of acquired epilepsy.
- To underscore the need for antiepileptogenesis therapies in TBI patients.
- To address the challenges in developing effective biomarkers for TBI-related epilepsy research.
Main Methods:
- Review of epidemiological studies on TBI and epilepsy.
- Analysis of the relationship between injury severity and epilepsy development.
- Discussion of the clinical research landscape for antiepileptogenesis therapies.
Main Results:
- Epilepsy risk approaches 50% in TBI cases with direct brain parenchyma injury.
- The delayed onset of epilepsy in TBI patients presents an opportunity for therapeutic development.
- Lack of reliable biomarkers currently impedes progress in antiepileptogenesis research.
Conclusions:
- TBI remains a leading cause of acquired epilepsy, necessitating further research.
- The development of valid biomarkers is essential for advancing antiepileptogenesis therapies.
- Increased severe head trauma in modern warfare underscores the urgency of addressing TBI and epilepsy.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...